Strategy& Insider cover art

Strategy& Insider

Strategy& Insider

Written by: Thomas Solbach Ghioia Irritier Jan-Philipp Loch
Listen for free

About this listen

 The Strategy& Insider podcast aims to explore some of the most critical future trends and their impacts. Strategy& talks to industry experts and leading practitioners from different sectors. The conversations will make you more familiar with key developments by providing you with insights that really matter. The first season will tackle some of the most fundamental questions in the healthcare industry. While technology has quickly transformed how we shop, bank, and travel, it yet has to impact on how we receive healthcare. The adoption of digitally enabled tools for diagnostics, treatment, and management, for example, has been rather modest - especially compared to what is already possible. Together with experts across all sectors including pharma executives, leading academics and practitioners at hospitals we will discuss how the healthcare industry is expected to change.PwC Strategy& (Germany) GmbH Economics Hygiene & Healthy Living Management Management & Leadership Physical Illness & Disease
Episodes
  • Strategy& Insider Episode 45 - Matching patients with the right medical specialists

    Strategy& Insider Episode 45 - Matching patients with the right medical specialists
    Apr 15 2026
    Nils von Dellingshausen is the CEO and co-founder of BetterDoc, a digital platform transforming how patients find the right doctor for their specific conditions. In this episode, he shares how his company uses proprietary data, expert physician panels, and a rigorous matching methodology to cut through misleading healthcare information and connect patients with their custom-fit medical specialists. He discusses the cultural barriers around second opinions, the critical line between AI-assisted information processing and human medical judgment, and his vision for indication-specific care pathways that follow patients throughout their entire healthcare journey. Tune in for an insightful conversation on patient empowerment, data-driven transparency, and the future of healthcare navigation.
    Show More Show Less
    48 mins
  • Strategy& Insider Episode 44 - Expanding access to essential medicines

    Strategy& Insider Episode 44 - Expanding access to essential medicines
    Mar 19 2026
    What does it take to get a life-changing medicine from regulatory approval to the patient who needs it? Isabell Remus, Global Head of Biosimilars at Sandoz, reveals why being approved and affordable isn't enough – and how the biosimilar industry learned that trust and education must come before market access. With $320 billion in biologic medicines losing patent exclusivity over the next decade, she explores the strategic complexities of launching at the exact moment a patent expires, the role of diversified manufacturing in strengthening supply chain resilience, and why expanding access to essential medications requires both purpose and commercial viability. An eye-opening conversation on making affordable healthcare a reality for millions of patients worldwide.
    Show More Show Less
    37 mins
  • Strategy& Insider Episode 43 - Building drug delivery spaceships

    Strategy& Insider Episode 43 - Building drug delivery spaceships
    Feb 19 2026
    In this episode, Dr. Kahina Lang, Executive Director and Head of Next Gen Drug Delivery at Merck Group, discusses her pioneering work developing targeted mRNA delivery systems using lipid nanoparticle (LNP) technology. She shares insights on building an internal startup within the world’s oldest pharmaceutical corporation, the technical innovations enabling precision medicine, and the future of cell and gene therapies. Tune in for an insightful conversation on how entrepreneurial leadership, digital-first research approaches, and open-innovation models are accelerating breakthrough therapeutics from the lab to the clinic.
    Show More Show Less
    41 mins
adbl_web_anon_alc_button_suppression_c
No reviews yet